
مقالات ISI ترجمه شده متفورمین

Keywords: متفورمین; Cationic lipid; Metformin; Biguanide; Intrinsic antitumor activity; TRAIL; Nanoparticles
مقالات ISI متفورمین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.

Keywords: متفورمین; Metformin; SCFA; Cancer; Butyrate producing taxa; Microbiome;

Keywords: متفورمین; Bone morphogenetic protein (BMP); Granulosa cells; Metformin; Smad and steroidogenesis; ActRII; activin type-II receptor; ALK; activin receptor-like kinase; AMPK; AMP-activated protein kinase; BMP; bone morphogenetic protein; BMPRII; BMP type-II receptor;

Keywords: متفورمین; Turnip; Brassica rapa; Metformin; Interaction; Liver; Rat;

Keywords: متفورمین; AMT; active motor threshold; cTBS; continuous theta burst stimulation; EMG; electromyogram; GA; gestational age; GDM; gestational diabetes mellitus; HOMA-IR; homeostatic model assessment for insulin resistance; HPA; hypothalamic-pituitary-adrenal; SI1mV;

Keywords: متفورمین; BCR; Belgian cancer registry; IMA; intermutualistic agency; NNSS; national number for social security; ICD; international classification of disease; DDD; defined daily dose; OS; overall survival; CSS; cancer specific survival; HR; hazard ratio; CI; confid

Keywords: متفورمین; Apoptosis; Metformin; Oxidative stress; Rapamycin; Testicular torsion/detorsion;

Keywords: متفورمین; Streptozotocin (PubChem CID: 29327); 2,4-Dinitrophenylhydrazine (PubChem CID: 3772977); Digitonin (PubChem CID: 6474107); Streptomycin sulfate (PubChem CID: 19648); 5,5â²-Dithiobis-2-nitrobenzoic acid (PubChem CID: 6254); Titanium (IV) oxysulfate-sulfuri

Keywords: متفورمین; ADMA; asymmetric dimethylarginine; cAMP; cyclic AMP; CVD; cardiovascular disease; CT; chemotherapy; DOX; doxorubicin; DDAH; dimethylarginine diaminohydrolase; eNOS; endothelial nitric oxide synthase; FSK; forskolin; HCY; homocysteine; HTRF; homogenous tim

Keywords: متفورمین; Metformin; Endothelium; Nitric oxide synthase; Obesity; Zucker;

Keywords: متفورمین; MDA; malondialdehyde; SOD; superoxide dismutase; TNF-α; tumor necrosis factor-alpha; DM; diabetes mellitus; MWM; Morris water maze; STZ; streptozotocin; T1DM; type 1 diabetes mellitus; T2DM; type 2 diabetes mellitus; Safranal; Diabetes; Learning and memo

Keywords: متفورمین; Exercise; Metformin; Oxygen consumption; Type 2 diabetes mellitus (T2DM);

Keywords: متفورمین; Type 2 diabetes mellitus-tuberculosis coinfection; Metformin; Lactic acidosis;

Keywords: متفورمین; aPKC; atypical protein kinase C; CBP; CREB binding protein; ChREBP; carbohydrate response element-binding protein; CREB; cAMP response element-binding protein; CRTC2; CREB-regulated transcription coactivator 2; FA; fatty acid; GIPR; glucose-dependent insu

Keywords: متفورمین; Metformin; Mode of action; Diabetes; Cancer; Polycystic ovarian syndrome; Alzheimer's disease;

Keywords: متفورمین; CAT; Catalase; DAI; Disease activity index; DSS; Dextran sulfate sodium; ELISA; Enzyme linked immunoassay; IBD; Inflammatory bowel disease; IL; Interleukin; α-LA; Alpha-lipoic acid; MDA; Malondialdehyde; NF-κB; Nuclear factor-kappa-B; PBS-BSA; Phosphate

Keywords: متفورمین; Metformin; Macrophage polarization; Palmitate; Inflammation; AMPK;

Keywords: متفورمین; Pharmaceutical pollutants; Degradation; Metformin; P25; Radical hydroxyl; Photocatalysis; Sunlight irradiation; Solar reactor;

Keywords: متفورمین; Bile acids; UHPLC-MS; Quantification; Metformin; db/db mice;

Keywords: متفورمین; AMD; age-related macular degeneration; Ap5A; di(adenosine)â5-penta-phosphate; ATP synthase; FoF1-ATP synthase; DR; diabetic retinopathy; ETC; electron transport chain; MTF; Metformin: OS, outer segment; PUFA; polyunsaturated fatty acids; ROI; reactive o

Keywords: متفورمین; Zebrafish; Pharmaceuticals; Metformin; Biomarkers; Endocrine disruption;

Keywords: متفورمین; Indicators; Pharmaceutically active compounds; Metformin; Guanylurea;

Keywords: متفورمین; insulin; glyburide; GDM; metformin;

Keywords: متفورمین; bone regeneration; mesenchymal stromal cells; metformin; organic cation transporters; osteogenesis; stem cells; umbilical cord;

Keywords: متفورمین; Metformin; Chitosan; Intrapocket dental film; Periodontitis; Rat model; Alveolar bone loss;

Keywords: متفورمین; Gestational diabetes; Pregnancy; CNKI; Metformin; Ethnicity; Race;

Keywords: متفورمین; Diabetes mellitus; Gliclazide; Glucose; Lipids; Metformin; Oxidative stress;

Keywords: متفورمین; dipeptidyl peptidase-4 inhibitor; drug-drug interactions; metformin; pharmacokinetics; teneligliptin;

Keywords: متفورمین; chronic kidney disease; CKD-MBD; high bone turnover; metformin; renal fibrosis; vascular calcification;

Keywords: متفورمین; T2DM; Type 2 diabetes mellitus; NG; normal glucose concentration; HG; high glucose concentration; mTORC; mammalian target of rapamycin complex; GLUT; glucose transporters; LKB1; Liver kinase B1; AMPK; AMP-activated protein kinase; AKT; Protein kinase B; A

Keywords: متفورمین; Depressive symptoms; Diabetes; Repositioning; Systematic review; Meta-analysis; Meta-regression; Inflammation; Insulin resistance; Pioglitazone; Metformin;

Keywords: متفورمین; Apoptosis; Caspase-3; Cell cycle arrest; Doxorubicin; Metformin; p21 expression;

Keywords: متفورمین; Metformin; Coagulation; Haemostasis; Biocompatibility;

Keywords: متفورمین; Oral cancer; Head and neck cancer; Mouth neoplasm; Hydroxymethylglutaryl-CoA reductase inhibitors; Metformin; Anti-inflammatory agents; Non-steroidal; Statins;

Keywords: متفورمین; Childhood obesity; Prevention plus; Motivational interviewing; Cardiometabolic risks; Metformin; Behavioral interventions;

Keywords: متفورمین; Translational geroscience; Healthspan; Longevity; Aging; Rapamycin; Metformin; mTOR; Companion animals;

Keywords: متفورمین; Metformin; LC-QQQ-MS; Clinical samples; Plasma concentrations; Forensics; Lactic acidosis; Post mortem;

Keywords: متفورمین; Metformin; Steady-state level; Patient-factors; Therapeutic dosage; Type-2 diabetes mellitus;

Keywords: متفورمین; diabetes mellitus; metformin; skin cancer; Taiwan; HR; hazard ratio; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; NHI; National Health Insurance; NMSC; nonmelanoma skin cancer; PS; propensity score; UV; ultrav

Keywords: متفورمین; Metformin; Cancer; Diabetes; Glucose-lowering therapies;